Cognitive training for Parkinson's (NCT06323278)
Improve cognitive function with training
- Trial ID
- NCT06323278
- Official Title
- Evaluation of the Cognitive Stimulation Treatment in Patients With Parkinson's Disease
- Goal
- Improve cognitive function with training
- Status
- RECRUITING
- Sponsor
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- Study Type
- OBSERVATIONAL
- Enrollment
- 68 participants
- Conditions
- Parkinson Disease
- Interventions
- Cognitive training
Summary For Families
The goal is to see whether a structured cognitive stimulation program can help people with Parkinson's who have mild cognitive impairment, by maintaining or improving memory, attention, planning, and everyday thinking. The approach uses regular, non-drug cognitive training sessions,guided exercises and activities meant to stimulate neural networks and strengthen thinking skills,and it is offered alongside usual care, so it does not replace or change levodopa or other medications. The trial is looking for adults 18 to 80 with a Parkinson's diagnosis who have had genetic screening, a MoCA raw score between about 15.5 and 22.23, have given consent, are not diagnosed with dementia, and are not treated with deep brain stimulation.
Locations
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Cognitive training. The goal is to see whether a structured cognitive stimulation program can help people with Parkinson's who have mild cognitive impairment, by maintaining or improving memory, attention, planning, and everyday thinking. The approach uses regular, non-drug cognitive training sessions,guided exercises and activities meant to stimulate neural networks and strengthen thinking skills,and it is offered alongside usual care, so it does not replace or change levodopa or other medications. The trial is looking for adults 18 to 80 with a Parkinson's diagnosis who have had genetic screening, a MoCA raw score between about 15.5 and 22.23, have given consent, are not diagnosed with dementia, and are not treated with deep brain stimulation.
- Who can participate?
- Participants must be between 18 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 4 years and 11 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Thinking & memory tests (non-invasive). Confirm the full schedule with the study coordinator.